arrow
W

W. Cameron Black

repare therapeut inc
H指数:34
被引数:3,713

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor

RP-1664的发现:一种具有口服生物利用度、选择性的首创新药PLK4抑制剂

2025-05-160
PRE
Charting a landmark-driven path forward for population genetics and ancient DNA research in Africa
2024-07-012
OAAI
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
2024-02-015
PRE
Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ
2022-09-2034
OA
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
2022-07-2627
OA
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors
2021-12-1557
OAAI
Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and Dyslipidemia
2011-06-28126
PREAI
Identification of a Nonbasic, Nitrile-Containing Cathepsin K Inhibitor (MK-1256) that is Efficacious in a Monkey Model of Osteoporosis
2008-09-2427
PREAI
The Discovery of RP-2119: A Potent; Selective; and Orally Bioavailable Polθ ATPase Inhibitor

RP-2119的发现:一种强效、选择性及口服生物利用性的Polθ ATP酶抑制剂

0
PRE